What does business valuation for US investors in the UAE cover? It is an independent, IVS-aligned valuation of a US-linked business or a UAE target acquired by a US company or fund, with a bridge to US GAAP reporting where required, using DCF, market multiples and net asset value with IFRS-compliant reporting. It supports corporate development, venture and growth investments, and preferred share and option valuation. Corvian Advisory provides it from Dubai as UAE-based valuation advice for US investors and US-linked transactions, through a CFA-led team with 15+ years of Big 4 experience. Fixed fee from USD 2,500, typically 2–4 weeks.
Independent, IVS-aligned and IFRS-compliant valuation for US corporates, venture and growth investors, and founders with UAE operations. We build the reporting bridge between IFRS and US GAAP into the work, and every report is signed by CFA, CA and ACCA qualified practitioners.
A CFA Charterholder and Chartered Accountant with Big 4 experience leads each US-linked engagement. Our team routinely works between IFRS and US GAAP financials, which matters when a US parent consolidates a UAE subsidiary.
Because the lead is hands-on, questions from your board, investors or auditors are answered by the person who made the call. For venture-stage companies we are explicit about which inputs are market evidence and which are judgement, so investors can challenge the right things.
Most US-linked mandates need more than one valuation. We provide the full range from the UAE, so one CFA-led team can value the target, allocate the purchase price and support reporting afterwards. Every report is IVS-aligned, with IFRS-compliant reporting.
Whole-business and stake valuation using DCF, market multiples and net asset value.
Per-share value for transactions, disputes between shareholders, partner exits and reporting.
Venture-method, DCF and round-based valuation for funding, secondary sales and cap table decisions.
Brands, customer relationships, technology and IP valued for deals, financing and reporting.
Allocation of the price paid across identifiable assets, liabilities and goodwill after an acquisition.
Recoverable amount and impairment analysis for goodwill and cash-generating units.
Fair value of options and employee share plans for grant, reporting and exit planning.
Fair value of real estate and operating assets within a business or asset-heavy transaction.
Corvian Advisory provides UAE-based valuation advice to US investors and on US-linked transactions, prepared to IVS with IFRS-compliant reporting. We are not a US-registered valuer. Where a statutory or regulatory valuation specific to the US is required, we work alongside a locally authorised valuer and coordinate our analysis with theirs.
For US-linked mandates we match the method to the stage: DCF and multiples for established companies, scenario and option-based methods for venture-stage ones.
Forecast cash flows discounted at a USD-based WACC that reflects UAE country risk, with the AED–USD peg treated as a stated assumption.
US, European and GCC comparables, adjusted for size, growth and liquidity, with revenue multiples for high-growth businesses.
Fair value of net assets under IFRS for holding companies and asset-heavy targets, with a US GAAP reconciliation where needed.
Equity value is allocated across common, preferred and option classes using a documented waterfall and option-pricing method.
Pricing UAE acquisition targets for US buyers.
Independent support for pre-money valuation.
Waterfall and option-pricing analysis across preferred and common.
IFRS to US GAAP reconciliation inputs for consolidation.
Fair value of options and restricted stock in UAE entities.
Purchase price allocation and impairment testing inputs.
US-linked UAE mandates concentrate in technology, services and consumer businesses, each with a different primary approach.
| Sector | Primary Approach | Key Value Driver |
|---|---|---|
| Software & SaaS | DCF, revenue multiples | ARR growth, net retention |
| E-Commerce & Marketplaces | Revenue multiples, DCF | Contribution margin, cohorts |
| Healthcare & Life Sciences | DCF, venture method | Pipeline, reimbursement mix |
| Professional Services | EV/EBITDA, DCF | Utilisation, client concentration |
| Consumer Brands | EV/EBITDA | Brand pricing power, distribution |
| Fintech | Venture method, DCF | Transaction volumes, take rate |
Fixed fees are agreed in writing before work begins, billed in USD, with no hourly billing and no scope creep.
One entity, straightforward financials, one or two methods.
Multiple methods, comparables and reporting bridge for M&A or investment decisions.
Multi-class equity, option-pricing analysis and IFRS 3 purchase price allocation.
A call on the transaction, share structure and the reporting standards your parent uses. Fixed fee agreed upfront.
Statements, cap table, term sheets and forecasts shared via a secure data room.
Normalisation, DCF and comparables, waterfall and option-pricing analysis where relevant, and a GAAP bridge.
A review meeting in which every major assumption is explained and any new information is fed into the analysis.
Signed report with methodology, assumptions, sensitivities and reconciliation of approaches, prepared to IVS and consistent with IFRS 13.
Answers to questions US-linked investors and founders commonly ask.
Share the transaction outline and we will confirm a fixed fee within one business day.